Cardiac disease in pregnancy: how AI technology can help midwives with frontline detection

The theme of this year’s World Health Day (April 7th)  is to recognise the work of nurses and midwives and remind world leaders of the critical role they play …

Ultromics achieves ISO 27001 certification

  Ultromics has received ISO 27001 certification. The standard recognises our commitment to data security and ensures, for patients, clinicians and healthcare providers, that personal healthcare information and other …

Ultromics receives FDA clearance

  Ultromics receives FDA clearance for its AI-powered decision support system, EchoGo Core.   AI automates cardiac analysis helping earlier detection of cardiovascular disease, enabling clinicians to improve patient …

Ultromics secures £10 million investment to bring AI heart diagnostics to hospitals

Ultromics, the UK start-up behind breakthrough artificial intelligence (AI) technology for the diagnosis of coronary heart disease, has raised £10 million in Series-A investment. The funding was led by …

Ultromics secures additional £1m investment from Woodford Investment Management

Ultromics is excited to announce our latest investor, Woodford Investment Management, who have added £1m to our recently closed £10m Series A round. Woodford Investment Management joins a group …

Artificial intelligence ‘to diagnose heart disease

AI early diagnosis could save heart and cancer patients

Ultromics CEO Ross Upton was interviewed on BBC

Ultromics AI platform to expand trials to 20 NHS hospitals

Artificial intelligence will improve medical treatments

*Pending FDA 510(k) clearance, not available for sale in the United States, not CE-marked

**CAUTION–Investigational device. Limited by Federal (or United States) law to investigational use